A Study of Radiotherapy Planning System Software ---- Zeus Cloud

Radiotherapy Clinical Trial

Official title:

A Multicenter Study on the Feasibility of a Radiotherapy Treatment Planning System (TPS) Software---Zeus Cloud

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04579718
• Other study ID #: GASTO-1062
• Status: Not yet recruiting
• Start date: November 1, 2020
• Est. completion date: October 31, 2022

Study information

• Verified date: October 2020
• Source: Sun Yat-sen University
• Contact: Bo Qiu, MD
• Phone: +86-020-87343031
• Email: qiubo[@]sysucc.org.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate the feasibility of Zeus Cloud TPS in the design of photon intensity modulated radiation therapy (IMRT) plan for tumors in various parts of the body.

Description:

This is a self-control, multi-center non-inferiority study. Subjects meeting inclusion criteria have radiation treatment plans designed by Zeus Cloud TPS and Eclipse treatment planning software from Varian, respectively. The qualities of two plans are compared.

This is a observational study as the two plans are not executed.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 63
• Est. completion date: October 31, 2022
• Est. primary completion date: October 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

1. Patients with confirmed brain glioma, nasopharyngeal carcinoma, lung cancer, esophageal cancer, gastric cancer, liver cancer, prostate cancer, cervical cancer and rectal cancer;

2. The medical imaging data (CT) of the subjects were complete and available;

3. Between 18 and 75 years old, regardless of gender;

Exclusion Criteria:

1. The patients had metal implants;

2. Not suitable for clinical trials judged by investigators.

Related Conditions & MeSH terms

• Radiotherapy

Intervention

Other:
• Zeus Cloud TPS V1.0
Zeus Cloud TPS V1.0 is used to design the radiotherapy plan for the subjects and the plan is evaluated.
• Eclipse
Eclipse TPS of Varian company is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Sun Yat-sen University	The Affilicated Suzhou Science and Technology Town Hospital, The First Affiliated Hospital of Soochow University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The qualification rate of treatment plans based on dosimetry		2 months
Secondary	The conformability index of radiation dose to the target		2 months
Secondary	single-field pass rate		2 months
Secondary	composite-field pass rate		2 months